Journals Library

An error occurred retrieving publication content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

These trials did not support the use of levetiracetam or zonisamide as first line treatments in focal epilepsy or levetiracetam for newly diagnosed generalised epilepsy at 12 months.

{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Anthony G Marson 1,*, Girvan Burnside 2, Richard Appleton 3, Dave Smith 4, John Paul Leach 5, Graeme Sills 1, Catrin Tudur-Smith 2, Catrin O Plumpton 6, Dyfrig A Hughes 6, Paula R Williamson 2, Gus Baker 1, Silviya Balabanova 7, Claire Taylor 7, Richard Brown 8, Dan Hindley 9, Stephen Howell 10, Melissa Maguire 11, Rajiv Mohanraj 12, Philip EM Smith 13

1 Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK
2 Department of Health Data Science, University of Liverpool, Liverpool, UK
3 The Roald Dahl EEG Unit, Alder Hey Children’s Health Park, Liverpool, UK
4 The Walton Centre NHS Foundation Trust, Liverpool, UK
5 School of Medicine, University of Glasgow, Glasgow, UK
6 Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK
7 Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK
8 Addenbrooke’s Hospital NHS Foundation Trust, Cambridge, UK
9 Bolton NHS Foundation Trust, Royal Bolton Hospital, Bolton, UK
10 Department of Neurology, Royal Hallamshire Hospital, Sheffield, UK
11 School of Medicine, University of Leeds, Leeds, UK
12 Salford Royal NHS Foundation Trust, Manchester, UK
13 The Alan Richens Epilepsy Unit, University Hospital of Wales, Cardiff, UK
* Corresponding author Email: a.g.marson@liverpool.ac.uk

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}

https://doi.org/{{metadata.DOI}}

Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Crossmark status check

Report Content

The full text of this issue is available as a PDF document from the Toolkit section on this page.

The full text of this issue is available as a PDF document from the Toolkit section on this page.

If you would like to receive a notification when this project publishes in the NIHR Journals Library, please submit your email address below.

Responses to this report

No responses have been published.

 

If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors.  Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

By submitting your response, you are stating that you agree to the terms & conditions

An error has occurred in processing the XML document